Spine Liverpool

About

The Pandemic Institute is positioned to leverage existing capabilities and assets to better prepare the world for future pandemics

The Pandemic Institute is headquartered in Liverpool, a city at the leading edge of innovative public health responses, and with a rich history of pandemic science. During COVID-19 the city of Liverpool’s civic leadership, academic institutions and health infrastructure combined powerfully on testing, vaccine development and the Events Research Programme. The collaboration led to the most agile public health response seen across the nation. The Pandemic Institute is the next stage in this journey.

We are proud to have Innova Medical Group, Inc., with its deep expertise in testing, unique offerings in diagnostic medical devices and services that help tackle some of the world’s most challenging healthcare problems, as a founding patron of the Institute.

Our leadership team

  • Matthew Baylis

    Matthew Baylis

    Director of the Pandemic Institute

    Matthew Baylis took up the Chair in Veterinary Epidemiology at the University of Liverpool in 2005. With fellowship funding from the Leverhulme Trust, in 2007 he established the Liverpool University Climate and Infectious Diseases of Animals group (LUCINDA). From 2010-15 he was head of the Department of Epidemiology and Population Health in the Institute of Infection and Global Health (IGH), then Research Strategy Lead. In 2019 he was appointed as Executive Dean of the newly formed Institute of Infection, Veterinary and Ecological Sciences (IVES).

  • Sarah Martindale

    Sarah Martindale

    Programme Manager

    Sarah Martindale completed her MSc in Molecular Biology of Parasites and Disease Vectors at the Liverpool School of Tropical Medicine (LSTM) in 2013 where, as part of her research project, she investigated the physical, social and economic impact of lymphatic filariasis on communities in Malawi. In 2014, she joined the Centre for Neglected Tropical Diseases (CNTD) at LSTM as a Programme Manager.

    Her key areas of expertise include programme design, oversight and monitoring of programme implementation and cross-sectoral collaboration. Sarah has a strong track record building partnerships between stakeholders, including collaborating with national governments and local experts in complex multicultural environments across Africa.

Founding partners

  • Liverpool City Council is the governing body for the city of Liverpool in Merseyside, England. It consists of 90 councillors, three for each of the city's 30 wards.

  • The University of Liverpool is a public research university based in the city of Liverpool, England. Founded as a college in 1881, it gained its Royal Charter in 1903 with the ability to award degrees and is also known to be one of the six original 'red brick' civic universities.

  • The Liverpool School of Tropical Medicine was established in 1898 and it was the first institution in the world dedicated to research and teaching in tropical medicine.

  • Liverpool John Moores University is a public research university in the city of Liverpool, England. The university can trace its origins to the Liverpool Mechanics' School of Arts, established in 1823.

  • Liverpool University Hospitals NHS Foundation Trust is the newly merged Trust responsible for managing Aintree University Hospital, Broadgreen Hospital, Liverpool University Dental Hospital and the Royal Liverpool University Hospital.

  • The Liverpool City Region is a combined authority region of England, centred on Liverpool, incorporating the local authority district boroughs of Halton, Knowsley, Sefton, St Helens, and Wirral.

  • KQ Liverpool is a 450-acre innovation district at the heart of Liverpool City Centre which is home to some of the world’s most influential names in science, health, technology, education, music and the creative and performing arts.

Strengths

  • Expertise

    Liverpool has extensive and world-leading expertise in pandemic research. The city is unique within the Higher Education ecosystem in the UK with medical, veterinary, public health, tropical medicine and behavioural science schools that network across Health & Life Science clusters in KQ Liverpool, Daresbury and Alderley Park. The city is therefore home to an exceptionally talented workforce, including ISARIC, a leading consortium of researchers collating clinical information on pathogens of public interest.

  • Capability

    Liverpool pioneered innovative approaches during the Covid-19 pandemic, including a whole city community testing pilot which cut transmission rates by a fifth, as well as hosting large-scale pilot events on behalf of the Government that provided evidence of how to safely reopen important sectors of the economy. Our city worked together to help our communities tackle the pandemic and develop Liverpool’s reputation as a leader in pandemic management and resilience. More broadly, Liverpool is a national leader in genomic sequencing and holds one of the richest global data sets of zoonotic pathogens. It is also home to the pioneering AGILE clinical trial platform and has extensive vaccine and pharmaceutical manufacturing experience.

  • Infrastructure

    Liverpool has a critical mass of civic organisations and HEIs acting as one system, leveraging their collective infrastructure to enable research across the pandemic lifecycle. It is also home to one of only five High Consequences Infectious Disease Units in the UK and hosts the Center for Global Vaccine Research, as well as a global biobank hub which can be leveraged and scaled rapidly. Additionally, the Founding Partners have significant global reach, with collaborations and hubs located across the world, which the Institute will build upon.

Founding patron

Innova

Innova Medical Group, Inc. delivers better global health outcomes with its deep expertise in testing, unique offerings in diagnostic medical devices and services that help tackle some of the world’s most challenging healthcare problems. Innova specializes in innovative screening, testing and diagnostics for cancer, heart disease, arterial calcification, stroke and virus detection focused on infectious disease. In response to the global pandemic, Innova developed an end-to-end ecosystem of rapid diagnostic and screening tests, along with digital reporting and tracing applications to help organizations manage the COVID-19 crisis.

Covid cell

Together we will lead the world in its understanding of and ability to manage pandemics, through an end-to-end approach to pandemic research.

Contact the institute

contact@thepandemicinstitute.org

The Spine, Liverpool, L7 8SZ